| |
| |
|
| Insider
Information: |
Powell Andrew Kenneth William |
| Relationship: |
Director |
| City: |
Newtown |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
59,990 |
|
|
Indirect Shares
|
34,600 |
|
|
| Direct
Value |
$215,846 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
94,590 |
|
|
| Total
Value |
$215,846 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -4.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
China Redstone Group Inc |
CGPI |
VP, G. Counsel and Cor... |
2007-11-16 |
3,650 |
2007-11-28 |
3,850 |
Premium* |
|
|
InterMune Inc |
ITMN |
EVP, GC & Secretary |
2014-09-29 |
0 |
2013-09-09 |
30,750 |
Premium* |
|
|
Medivation Inc |
MDVN |
SVP, General Counsel &... |
2016-09-28 |
0 |
2015-05-27 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2024-03-04 |
28,863 |
2018-05-16 |
0 |
Premium* |
|
|
Landec Corp |
LNDC |
Director |
2022-06-04 |
27,477 |
2019-01-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2024-03-04 |
4 |
B |
$1.25 |
$7,500 |
D/D |
6,000 |
28,863 |
2.39 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2024-03-01 |
4 |
B |
$1.23 |
$10,455 |
D/D |
8,500 |
22,863 |
2.39 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,507 |
14,363 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2022-11-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
9,856 |
0 |
- |
|
| LNDC |
Landec Corp |
Director |
– • – |
2022-06-04 |
4 |
A |
$9.50 |
$67,061 |
D/D |
7,059 |
27,477 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2022-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,356 |
13,856 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2022-05-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
709 |
10,500 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2021-11-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,500 |
11,209 |
0 |
- |
|
| LNDC |
Landec Corp |
|
– • – |
2021-06-01 |
4 |
A |
$11.64 |
$96,647 |
D/D |
8,303 |
20,418 |
0 |
- |
|
| LNDC |
Landec Corp |
|
– • – |
2020-10-15 |
4 |
A |
$10.36 |
$22,792 |
D/D |
2,200 |
12,115 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2020-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,333 |
16,709 |
0 |
- |
|
| LNDC |
Landec Corp |
Director |
– • – |
2020-05-28 |
4 |
A |
$10.99 |
$65,940 |
D/D |
6,000 |
9,915 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2020-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,876 |
9,376 |
0 |
- |
|
| LNDC |
Landec Corp |
Director |
– • – |
2019-05-30 |
4 |
OE |
$9.91 |
$28,888 |
D/D |
2,915 |
3,915 |
0 |
- |
|
| LNDC |
Landec Corp |
Director |
• • – |
2019-01-11 |
4 |
B |
$11.62 |
$6,101 |
D/D |
525 |
1,000 |
2.39 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2018-05-16 |
4 |
B |
$19.12 |
$9,560 |
D/D |
500 |
500 |
2.39 |
- |
|
| MDVN |
Medivation Inc |
SVP, General Counsel & Crp Sec |
• – – |
2016-09-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,920) |
0 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP, General Counsel & Crp Sec |
• – – |
2016-09-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,597) |
0 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP, General Counsel & Crp Sec |
• – – |
2016-06-06 |
4 |
S |
$60.42 |
$155,763 |
D/D |
(2,578) |
28,517 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP, General Counsel & Crp Sec |
• – – |
2016-02-18 |
4/A |
A |
$0.00 |
$0 |
D/D |
9,300 |
29,930 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP, General Counsel & Crp Sec |
• – – |
2016-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,300 |
38,250 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP, General Counsel & Crp Sec |
• – – |
2015-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,215 |
10,315 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP, General Counsel & Crp Sec |
• – – |
2015-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100 |
|
- |
|
| ITMN |
InterMune Inc |
EVP, GC & Secretary |
• – – |
2014-09-29 |
4 |
D |
$74.00 |
$22,496 |
D/D |
(304) |
0 |
0 |
- |
|
| ITMN |
InterMune Inc |
EVP, GC & Secretary |
• – – |
2014-09-29 |
4 |
D |
$74.00 |
$573,500 |
D/D |
(7,750) |
304 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
